Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Feb;11(1):139-142.
doi: 10.21037/hbsn-21-517.

Two is better than one: combinatorial receptor targeting enhances hepatocellular carcinoma (HCC) therapeutic response

Celia Sequera  1 , Flavio Maina  1
Affiliations
Editorial

Two is better than one: combinatorial receptor targeting enhances hepatocellular carcinoma (HCC) therapeutic response

Celia Sequera et al. Hepatobiliary Surg Nutr. 2022 Feb.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://hbsn.amegroups.com/article/view/10.21037/hbsn-21-517/coif). The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Schematic representation of the effects of lenvatinib alone and in combination with gefitinib on HCC cells, proposed by Jin et al. HCC, hepatocellular carcinoma.
See this image and copyright information in PMC

Comment on

  • EGFR activation limits the response of liver cancer to lenvatinib.
    Jin H, Shi Y, Lv Y, Yuan S, Ramirez CFA, Lieftink C, Wang L, Wang S, Wang C, Dias MH, Jochems F, Yang Y, Bosma A, Hijmans EM, de Groot MHP, Vegna S, Cui D, Zhou Y, Ling J, Wang H, Guo Y, Zheng X, Isima N, Wu H, Sun C, Beijersbergen RL, Akkari L, Zhou W, Zhai B, Qin W, Bernards R. Jin H, et al. Nature. 2021 Jul;595(7869):730-734. doi: 10.1038/s41586-021-03741-7. Epub 2021 Jul 21. Nature. 2021. PMID: 34290403

References

    1. Zucman-Rossi J, Villanueva A, Nault JC, et al. Genetic Landscape and Biomarkers of Hepatocellular Carcinoma. Gastroenterology 2015;149:1226-1239.e4. 10.1053/j.gastro.2015.05.061 - DOI - PubMed
    1. Llovet JM, Zucman-Rossi J, Pikarsky E, et al. Hepatocellular carcinoma. Nat Rev Dis Primers 2016;2:16018. 10.1038/nrdp.2016.18 - DOI - PubMed
    1. Villanueva A. Hepatocellular Carcinoma. N Engl J Med 2019;380:1450-62. 10.1056/NEJMra1713263 - DOI - PubMed
    1. Cancer Genome Atlas Research Network . Electronic address: wheeler@bcm.edu; Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell 2017;169:1327-1341.e23. 10.1016/j.cell.2017.05.046 - DOI - PMC - PubMed
    1. Nagel R, Semenova EA, Berns A. Drugging the addict: non-oncogene addiction as a target for cancer therapy. EMBO Rep 2016;17:1516-31. 10.15252/embr.201643030 - DOI - PMC - PubMed